These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25572558)

  • 1. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.
    Tsukuya G; Matsumoto K; Fukuyama S; Crawford B; Nakanishi Y; Ichinose M; Machida K; Samukawa T; Ninomiya T; Kiyohara Y; Inoue H;
    Allergol Int; 2015 Jan; 64(1):49-53. PubMed ID: 25572558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G; Samukawa T; Matsumoto K; Fukuyama S; Kumamoto T; Uchida A; Koriyama C; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.
    Samukawa T; Matsumoto K; Tsukuya G; Koriyama C; Fukuyama S; Uchida A; Mizuno K; Miyahara H; Kiyohara Y; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1469-1481. PubMed ID: 28553099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Performance of Two Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Chinese General Population.
    Liu M; Yin D; Wang Y; Wang W; Fu T; Duan Y; Hu M; Huang K
    Int J Chron Obstruct Pulmon Dis; 2023; 18():541-552. PubMed ID: 37065634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
    Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis.
    Gu Y; Zhang Y; Wen Q; Ouyang Y; Shen Y; Yu H; Wan C; Zhu J; Wen F
    Ann Med; 2021 Dec; 53(1):1198-1206. PubMed ID: 34282697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study.
    Matsumoto K; Seki N; Fukuyama S; Moriwaki A; Kan-o K; Matsunaga Y; Noda N; Yoshida M; Koto H; Takata S; Nakanishi Y; Kiyohara Y; Inoue H;
    Respir Investig; 2015 Jan; 53(1):22-9. PubMed ID: 25542600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.
    Hanibuchi M; Saijo A; Mitsuhashi A; Kajimoto T; Kitagawa T; Nishioka Y
    Respir Investig; 2022 Nov; 60(6):815-821. PubMed ID: 36057534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Six Chronic Obstructive Pulmonary Disease Screening Questionnaires in the Chinese Population.
    Zhou J; Yu N; Li X; Wang W
    Int J Chron Obstruct Pulmon Dis; 2022; 17():317-327. PubMed ID: 35177900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
    Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP;
    JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
    Siddharthan T; Pollard SL; Quaderi SA; Rykiel NA; Wosu AC; Alupo P; Barber JA; Cárdenas MK; Chandyo RK; Flores-Flores O; Kirenga B; Miranda JJ; Mohan S; Ricciardi F; Sharma AK; Das SK; Shrestha L; Soares MO; Checkley W; Hurst JR;
    JAMA; 2022 Jan; 327(2):151-160. PubMed ID: 35015039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
    Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
    COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS).
    Martinez FJ; Raczek AE; Seifer FD; Conoscenti CS; Curtice TG; D'Eletto T; Cote C; Hawkins C; Phillips AL;
    COPD; 2008 Apr; 5(2):85-95. PubMed ID: 18415807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV₁/FEV₆ for the diagnosis of COPD].
    Miravitlles M; Llor C; Calvo E; Diaz S; Díaz-Cuervo H; Gonzalez-Rojas N
    Med Clin (Barc); 2012 Nov; 139(12):522-30. PubMed ID: 22015009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Effectiveness of the COPD Assessment Test (CAT) in Screening for Chronic Obstructive Pulmonary Disease.
    Al Wachami N; Boumendil K; Arraji M; Iderdar Y; Mourajid Y; Ghosne N; Benmoussa A; Khalis M; Korrida A; Laamiri FZ; Lajane H; Louerdi ML; El Madani S; Chahboune M
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1623-1633. PubMed ID: 39011121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining case-finding methods for COPD in primary care: a large, two-stage design study.
    Soriano JB; Molina J; Miravitlles M
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):106-111. PubMed ID: 29297434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of COPD Population Screener Questionnaire in Chinese Population: A National Multicenter Study.
    Zhan Z; Ma Y; Chen Y; Zhang J; Li W; He Z; Xie J; Zhao H; Xu A; Peng K; Wang G; Zeng Q; Yang T; Chen Y; Wang C
    Respiration; 2023; 102(12):995-1002. PubMed ID: 38048758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.